Introduction: It is widely believed that discovery of specific, sensitive, and reliable tumor biomarkers can improve the treatment of cancer. Currently, there are no obvious targets that can be used in treating triple-negative breast cancer (TNBC). Methods: To better understand TNBC and find potential biomarkers for targeted treatment, we combined a novel hydrophobic fractionation protocol with mass spectrometry LTQ-orbitrap to explore and compare the hydrophobic sub-proteome of TNBC with another subtype of breast cancer, hormone-receptor- positive-Her2-negative breast cancer (non-TNBC). Results: Hydrophobic sub-proteome of breast cancer is rich in membrane proteins. Hundreds of proteins with various defined key cellular functions were identified from TNBC and non-TNBC tumors. In this study, protein profiles of TNBC and non-TNBC were systematically examined, compared, and validated. We have found that nine keratins are down-regulated and several heat shock proteins are up-regulated in TNBC tissues. Our study may provide insights of molecules that are responsible for the aggressiveness of TNBC. Conclusion: The initial results obtained using a combination of hydrophobic fractionation and nano-LC mass spectrometry analysis of these proteins appear promising in the discovery of potential cancer biomarkers and bio-signatures. When sufficiently refined, this approach may prove useful in improving breast cancer treatment. © 2010 The Author(s).
CITATION STYLE
Lu, M., Whelan, S. A., He, J., Saxton, R. E., Faull, K. F., Whitelegge, J. P., & Chang, H. R. (2010). Hydrophobic proteome analysis of triple negative and hormone-receptor- positive-her2-negative breast cancer by mass spectrometer. Clinical Proteomics, 6(3), 93–103. https://doi.org/10.1007/s12014-010-9052-1
Mendeley helps you to discover research relevant for your work.